Preclinical Research

FDA COVID-19 weekly action and advice update

13-Jan-2021 By Jenni Spinner

Industry professionals and consumers alike continue to look to the US agency for action, advice and news related to the global COVID-19 response.

AI-driven drug discovery collaboration to tackle neurological diseases

12-Jan-2021 By Jenni Spinner

Sosei Heptares and PharmEnable will harness artificial intelligence-enabled technology and advanced chemistry to explore neurological disease solutions.

Repurposing existing drugs accelerates discovery: XenoTech

12-Jan-2021 By Jenni Spinner

Exploring alternative uses for drugs tapped for other indications, can save considerable time and money in discovery, according to an expert from the CRO.

Lexaria broadens COVID-19 drug exploration program

11-Jan-2021 By Jenni Spinner

The drug delivery platform company is exploring the viability of remdesivir and other potential treatments for the virus using its DehydraTECH technology.

Phesi, Sensyne Health partner on synthetic arm tech for trials

07-Jan-2021 By Jenni Spinner

The two organizations will collaborate on development of synthetic arms for clinical studies, drawing from millions of patient records and trial subject.

Clinical informatics company raises $21.5m to fund tech

23-Dec-2020 By Jenni Spinner

Ovation.io will harness the funding to develop software and data products supporting drug discovery and development, creating diagnostics and more.

‘Explosion’ of health data fuels pharma advances: Linguamatics

22-Dec-2020 By Jenni Spinner

A leader from the IQVIA company explains how the boom in the volume and quality of data, and advanced analysis, can speed and streamline drug development.

Collaboration to chart AI-generated map of the immune system

21-Dec-2020 By Jenni Spinner

A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.

Sanofi joins Aqemia to develop COVID-19 treatments

21-Dec-2020 By Jenni Spinner

The pharma firm will lend support to Aqemia’s high-tech drug discovery tools in order to work on discovery and development of therapies for the virus.

Biomarkers pave the way to personalized care: Quanterix

21-Dec-2020 By Jenni Spinner

An executive from the digital biomarker tech company explains the myriad benefits of biomarker analysis in advancing precision health solutions.

Looking back, thinking ahead: industry leaders talk trends

16-Dec-2020 By Jenni Spinner

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

Sanofi renews WHO partnership on Neglected Tropical Diseases

15-Dec-2020 By Rachel Arthur

Sanofi has made a new five-year, $25m partnership agreement with the World Health Organization (WHO) to fight Neglected Topical Diseases (NTD); and eliminate sleeping sickness by 2030.

Chicago life-sciences incubator to open in early 2021

14-Dec-2020 By Jenni Spinner

The resource—designed to provide seed capital, lab space, offices and management consulting to researchers—is opening its doors earlier than expected.

Current FDA COVID-19 developments

09-Dec-2020 By Jenni Spinner

The agency continues to offer advice, resources and oversight during the pandemic to help develop tests, treatments and other solutions for the virus.